Member Info for donnodertrader

there has never been any news of novayct having an antibody test

Bramley I can only conclude, having watched the great rns((s), with no positive surge in share price, that the forward looking statements of the company did not include the actual figures that the market was looking for. If that is the case they should be wary of giving good news without the figures to go with it.

so difficult to believe the share price is even worse than yesterday

yes good rns(s), even great rns(s) but each one had a disappointing impact on the market. it has not necessarily happened with other shares, but this share needs the detail of the magnitude of the orders to satisfy the market. that is what has been missing. I hope it is put right very soon.

Well I hope it has taught this great company a lesson on the danger of missing out vital information in rns(s).

….and why would that be?

nothing confused about my thinking! you may disagree with my view, but that most certainly does not make me confused.

Everything I say is in the context of recognising the excellent work the company is doing in making a huge contribution to the worldwide challenge of covid-19.

Today, which should have been a day of milk and honey, turned into a disaster. The reason: a rns which focused on the great work of the company; but which failed to bottom out the numbers actually involved.

Recent rns(s) have bemused me, bewildered me, and today distressed me. Each of these rns(s) gave positive information about the direction the company is moving in. But each rns failed to give the figures involved, and these rns(s) led to no impact on share price or a reduction in share price. The common factor was the theoretical information about where the company is going, but this information was received by the market as MANANA, MANANA, MANANA.
In essence, the very positive message of the information provided was undone by the lack of detailed information on:
The capacity of the outsourced manufacturing
The relationship between capacity and the demand for the product
The potential demand for the new form of test
The impact of the new form of test on the demand for the existing test

To the Board, please think carefully about how your very positive messages are being received by the market and pitch your rns(s) accordingly.

But please remember, all in the context of doing a great job in contributing to fighting this dreadful virus.

I wish you had had them on this morning

68m

it is difficult to maintain faith when, in response to good news, there is such a fall in the share price. it does not make sense.

the key message is that if a rns for ncyt is based on theory and not new figures then the sp falls!!! I am not convinced that this was necessary.

yes I agree can anyone explain why, after a tree shake, the sp remains so low??

Michaelhighbar hi thanks I was thinking along the same lines, but it was not so clearly formulated in my mind. It is about time we saw some results on the cancer project, patience does not last forever.

HRG isn't it obvious!!!

I would be very surprised if they went looking for cash. They must be awash with it. they receive cash up front for orders.

was it when the camera pulled back and it showed products on the table in front of him?

believe me I am not arguing against you he seemed to mention Puritain Medical Products, US Cotton, Abbott Labs and ThermoFischer I cannot find the reference to Premier?

Allan he mentioned ThermoFisher was that the reference?

on CNN ? I am watching but must have missed it what was the context so I can rewind thanks